Three biomarkers ( HER2 , PD‐L1 , and microsatellite status) in a large cohort of metastatic gastroesophageal adenocarcinomas: The MD Anderson Cancer Center experience
International Journal of Cancer · 2024
DOI: 10.1002/ijc.35090 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Matheus Sewastjanow-Silva und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Adenocarcinoma, Biomarkers, Tumor, Stomach Neoplasms, Esophageal Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Golfers Against Cancer, NCI NIH HHS, Stupid Strong Foundation and Gastric Cancer Foundation (V Foundation).
Abstract (Originalsprache)
Human epidermal growth factor receptor‐2 (HER2), programmed death‐ligand 1 (PD‐L1), and microsatellite (MS) status are well‐established biomarkers in gastroesophageal adenocarcinomas (GEAs). However, it is unclear how the combination of these biomarkers is associated with clinicopathological factors and prognosis. This retrospective study included baseline metastatic GEA patients who were tested for all three biomarkers (HER2, PD‐L1, and MS status) at the MD Anderson Cancer Center between 2012 and 2022. Stratification was performed according to the combination of biomarker profiles: triple negative (TN), single positive (SP), and multiple positive (MP). Comparative analyses of clinicopathological factors and survival using combinations of biomarkers were performed. Among the 698 GEA patients analyzed, 251 (36.0%) were classified as TN, 334 (47.9%) as SP, and 113 (16.1%) as MP. The MP group showed a significant association with tumors located in the esophagus ( p < .001), well to moderate differentiation ( p < .001), and the absence of signet ring cells ( p < .001). In the survival analysis, MP group had a significantly longer overall survival (OS) compared to the other groups (MP vs. TN, p < .001 and MP vs. SP, p < .001). Multivariate Cox regression analysis revealed that MP serves as an independent positive prognostic indicator for OS (hazard ratio = 0.63, p < .01). Our findings indicate that MP biomarkers are associated with a favorable prognosis in metastatic GEA. These results are reflective of clinical practice and offer valuable insights into how therapeutics and future biomarkers could influence therapy/prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
ORCID-Profile: Matheus Sewastjanow-Silva, Ahmed Abdelhakeem
Förderung
- Golfers Against Cancer
- NCI NIH HHS
- Stupid Strong Foundation and Gastric Cancer Foundation (V Foundation)
- Anonymous Donor
- John Armstrong Fund
- Torrey Coast Foundation
- Zeus Immunology Research Fund
- The Richard L Duchossois Memorial Foundation
Zitieren
APA
Sewastjanow-Silva, M., Kwiatkowski, E., Yamashita, K., Abdelhakeem, A., Yoshimura, K., Vicentini, E. R., Pizzi, M. P., Jin, J., Fan, Y., Zou, G., Wang, L., Yin, F., Dhar, S. S., Blum Murphy, M., Mares, J. E., Li, J. J., Gan, Q., Waters, R. E., Rogers, J. E., & Ajani, J. A. (2024). Three biomarkers ( HER2 , PD‐L1 , and microsatellite status) in a large cohort of metastatic gastroesophageal adenocarcinomas: The MD Anderson Cancer Center experience. International Journal of Cancer. https://doi.org/10.1002/ijc.35090
Vancouver
Sewastjanow-Silva M, Kwiatkowski E, Yamashita K, Abdelhakeem A, Yoshimura K, Vicentini ER, et al. Three biomarkers ( HER2 , PD‐L1 , and microsatellite status) in a large cohort of metastatic gastroesophageal adenocarcinomas: The MD Anderson Cancer Center experience. International Journal of Cancer. 2024. doi:10.1002/ijc.35090
BibTeX
@article{SewastjanowSilva2024,
author = {Sewastjanow-Silva, Matheus and Kwiatkowski, Evan and Yamashita, Kohei and Abdelhakeem, Ahmed and Yoshimura, Katsuhiro and Vicentini, Ernesto R and Pizzi, Melissa P and Jin, Jiankang and Fan, Yibo and Zou, Gengyi and Wang, Lingzhi and Yin, Feng and Dhar, Shilpa S and Blum Murphy, Mariela and Mares, Jeannette E and Li, Jenny J and Gan, Qiong and Waters, Rebecca E and Rogers, Jane E and Ajani, Jaffer A},
title = {Three biomarkers ( HER2 , PD‐L1 , and microsatellite status) in a large cohort of metastatic gastroesophageal adenocarcinomas: The MD Anderson Cancer Center experience},
journal = {International Journal of Cancer},
year = {2024},
doi = {10.1002/ijc.35090}
}
EUVIMED